Screening for Retinopathy of Prematurity: Results of a Retrospective 3-Year Study of 502 Infants

Journal of Pediatric Ophthalmology and Strabismus

Volumn 41, Issue 1, 2004, Pages 31-34

  Conrath, John G ^a   Hadjadj, Eve J ^a   Forzano, Olivier ^a   Denis, Daniele ^a   Millet, Veronique ^a   Lacroze, Valerie ^a   Ridings, Bernard ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH WEIGHT; DIODE LASER; HUMAN; INFANT; MAJOR CLINICAL STUDY; OPHTHALMOSCOPY; PREMATURITY; RETINA BLOOD VESSEL; RETINOPATHY; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SCLERA BUCKLING PROCEDURE; SCREENING TEST;

EID: 0346502966     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/0191-3913-20040101-08     Document Type: Article

References (21)

1. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics 1999;104:e26.
2. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628-1640.
3. Saunders RA, Donahue ML, Christmann LM, et al. Racial variation in retinopathy of prematurity. Arch Ophthalmol 1997; 115:604-608.
4. The Committee for Classification of Retinopathy of Prematurity. An international classification for retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-1134.
5. Subhani M, Combs A, Weber P, Gerontis C, De Cristofaro JD. Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants. Pediatrics 2001;107:656-659.
6. Schalij-Delfos NE, Zijlmans BL, Wittebol-Post D, Tan KE, Cats BP. Screening for retinopathy of prematurity: do former guidelines still apply? J Pediatr Ophthalmol Strabismus 1996;33:35-38.
7. Goble RR, Jones HS, Fielder AR. Are we screening too many babies for retinopathy of prematurity? Eye 1997;11 (part 4):509-514.
8. Gun TR, Easdown J, Outerbridge EW, Manda VJ. Risk factors in retrolental fibroplasia. Pediatrics 1980;65:1096-1100.
9. Hammer ME, Mullen PW, Ferguson JG, Pai S, Cosby C, Jackson KL. Logistic analysis of risk factors in acute retinopathy of pre-maturity. Am J Ophthalmol 1986;102:1-6.
10. 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977;60:655-668.
11. Brown DR, Biglan AW, Stretavsky MM. Retinopathy of prematuity: the relationship with intraventicular hemorrhage and bronchopulmonary dysplasia. J Pediatr Ophthalmol Strabismus 1990;27:268-271.
12. Clark C, Gibbs JA, Maniello R, Outerbridge EW, Aranda JV. Blood transfusion: a possible risk factor in retrolental fibroplasia. Acta Paediatr Scand 1981;70:537-539.
13. Mittal M, Dhanireddy R, Higgins RD. Candida sepsis and association with retinopathy of prematurity. Pediatrics 1998;101(4 part 1):654-657.
14. Bancalari E, Flynn J, Goldberg RN, et al. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 1987;79:663-669.
15. Higgins RD, Mendelsohn AL, DeFeo MJ, Ucsel R, Hendricks-Munoz KD. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol 1998;116:601-605.
16. Repka MX, Hudak ML, Parsa CR, Tielsch JM. Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmology 1992;99:531-536.
17. Repka MX, Hardy RJ, Phelps DL, Summers CG. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol 1993;111:618-620.
18. Darlow BA, Horwood LJ, Clemett RS. Retinopathy of prematurity: risk factors in a prospective population-based study. Paediatr Perinat Epidemiol 1992;6:62-80.
19. Mizoguchi MB, Chu TG, Murphy FM, Willits N, Morse LS. Dopamine use is an indicator for the development of threshold retinopathy of prematurity. Br J Ophthalmol 1999;83:425-428.
20. Bullard SR, Donahue SP, Feman SS, Sinatra RB, Walsh WF. The decreasing incidence and severity of retinopathy of prematurity. J AAPOS 1999;3:321-322.
21. Blair BM, O'halloran HS, Pauly TH, Stevens JL. Decreased incidence of retinopathy of prematurity, 1995-1997. J AAPOS 2001; 5:118-122.